Richard Newcomb Stillwell - Mar 15, 2023 Form 4 Insider Report for Tonix Pharmaceuticals Holding Corp. (TNXP)

Role
Director
Signature
/s/ Jessica Morris as attorney-in-fact
Stock symbol
TNXP
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
4
Date filed
3/16/2023, 07:43 PM
Next filing
May 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNXP Stock Option Award $0 +83K $0.00 83K Mar 15, 2023 Common Stock 83K $0.56 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
F2 This option vests on the Issuer's 2023 Annual Meeting of Stockholders.